Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used ...

The research team shared their study results today in a poster presentation at the American Academy of ... 16 underwent ...

Catching up with Tal and Jacob Zlotnitsky, who protested against Trump's "Muslim ban" at Dulles International Airport in 2017 ...

Even if you’ve never heard of Michael Mann, you will have felt his baleful influence on your energy bills. He is the inventor ...

The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...

New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramideand ...

Cytokinetics (CYTK) announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...

The threat to shoot up a synagogue, coming just ahead of the Sabbath, caught the attention of a Jewish organization called ...

Patients with asthma who used depemokimab tolerated treatment well while experiencing reductions in rates of clinically ...